RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus
Lupus Nephritis

Interventions

BIOLOGICAL: CABA-201
BIOLOGICAL: CABA-201

Sponsor

Cabaletta Bio